Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis - Scorecard - MDSpire

Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis

  • By

  • Rodrigo R. de Sena

  • Kleyton de C Mesquita

  • Letícia F. Barroso

  • Paola B. E. Canabrava

  • Fernando Zanghelini

  • Ciro M. Gomes

  • March 18, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsAdd clinical implications of the targeted pathways.
Target Population
Care Setting

Key Highlights

  • highlight_3

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • I
      • n
      • c
      • l
      • u
      • d
      • e
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • f
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • i
      • n
      • t
      • e
      • r
      • v
      • a
      • l
      • s
      • .

      Risks

        Patient & Prescribing Data

        Detail the impact of interruptions on treatment efficacy.

        Clinical Best Practices

        • best_practice_2

        References

        Original Source(s)

        Evaluation of the Safety and Efficacy of Scheduled Temporary Withdrawal Versus Ongoing Maintenance of Interleukin Inhibitors in Psoriasis Patients: A Systematic Review and Network Meta-Analysis

        • by Rodrigo R. de Sena, Kleyton de C Mesquita, Letícia F. Barroso, Paola B. E. Canabrava, Fernando Zanghelini, Ciro M. Gomes

        • March 18, 2026

        Related Content

        Top 10 Evidence-Based Essentials in Dermatology

        A structured framework of guidelines, trials, therapies, and tools used in clinical practice

        Efficacy and Safety of Tildrakizumab for Treatment of Moderate-to-Severe Scalp Psoriasis in Patients with Obesity Over 52 Weeks

        GLP-1 Agents May Reduce Psoriasis Severity

        National Psoriasis Foundation review highlights limited evidence and potential metabolic links.